Kidney-specific gene targeting: Insight into thiazolidinedione-induced fluid retention

Nephrology

Volumn 11, Issue 3, 2006, Pages 201-206

  Yang, Tianxin ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Conditional gene targeting; Cre loxP; Kidney; Peroxisome proliferator activated receptor subtype

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2,4 THIAZOLIDINEDIONE DERIVATIVE; AMILORIDE; AQUAPORIN 2; CADHERIN; CRE RECOMBINASE; FARGLITAZAR; GAMMA GLUTAMYLTRANSFERASE; HOX PROTEIN; LINOLEIC ACID; LYSOPHOSPHATIDIC ACID; NEPHRIN; OSTEOGENIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PODOCIN; RENIN; ROSIGLITAZONE; SODIUM GLUCOSE COTRANSPORTER; TAMM HORSFALL GLYCOPROTEIN; TRANSCRIPTION FACTOR PAX2; TRANSCRIPTION FACTOR PAX8; TROGLITAZONE; VASOPRESSIN;

DNA FLANKING REGION; DNA RECOMBINATION; EMBRYONIC STRUCTURES; EXON; FLUID RETENTION; GENE FUNCTION; GENE TARGETING; GENETIC LINKAGE; GLOMERULUS; HEART FAILURE; HUMAN; IMMUNOCHEMISTRY; INTRON; JUXTAGLOMERULAR CELL; KIDNEY; KIDNEY COLLECTING TUBULE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE; KNOCKOUT MOUSE; LOXP SITE; LUNG EDEMA; MESENCHYME; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIPHERAL EDEMA; PODOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SOUTHERN BLOTTING; TRANSGENE; WEIGHT GAIN;

ANIMALS; BODY FLUIDS; HUMANS; KIDNEY; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); THIAZOLIDINEDIONES;

EID: 33744799047     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00566.x     Document Type: Review

References (47)

1. Bronson SK, Smithies O. Altering mice by homologous recombination using embryonic stem cells. J. Biol. Chem. 1994 269 : 27155 8.
2. Barak Y, Nelson MC, Ong ES et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell 1999 4 : 585 95.
3. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 1994 265 : 103 6.
4. Igarashi P. Kidney-specific gene targeting. J. Am. Soc. Nephrol. 2004 15 : 2237 9.
5. Stricklett PK, Nelson RD, Kohan DE. The Cre/loxP system and gene targeting in the kidney. Am. J. Physiol. 1999 276 : F651 7.
6. Gawlik A, Quaggin SE. Deciphering the renal code: Advances in conditional gene targeting. Physiology (Bethesda) 2004 19 : 245 52.
7. Stec DE, Sigmund CD. Modifiable gene expression in mice: Kidney-specific deletion of a target gene via the cre-loxP system. Exp. Nephrol. 1998 6 : 568 75.
8. Sternberg N, Hamilton D. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J. Mol. Biol. 1981 150 : 467 86.
9. Nelson RD, Stricklett P, Gustafson C et al. Expression of an AQP2 Cre recombinase transgene in kidney and male reproductive system of transgenic mice. Am. J. Physiol. 1998 275 : C216 26.
10. Ge Y, Ahn D, Stricklett PK et al. Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality. Am. J. Physiol. Renal Physiol. 2005 288 : F912 20.
11. Stricklett PK, Taylor D, Nelson RD, Kohan DE. Thick ascending limb-specific expression of Cre recombinase. Am. J. Physiol. Renal Physiol. 2003 285 : F33 9.
12. Eremina V, Wong MA, Cui S, Schwartz L, Quaggin SE. Glomerular-specific gene excision in vivo. J. Am. Soc. Nephrol. 2002 13 : 788 93.
13. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, Holzman LB. Podocyte-specific expression of cre recombinase in transgenic mice. Genesis 2003 35 : 39 42.
14. Moeller MJ, Soofi A, Hartmann I et al. Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J. Am. Soc. Nephrol. 2004 15 : 61 7.
15. Rubera I, Poujeol C, Bertin G et al. Specific Cre/Lox recombination in the mouse proximal tubule. J. Am. Soc. Nephrol. 2004 15 : 2050 56.
16. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 2002 110 : 341 50.
17. Yu J, Carroll TJ, McMahon AP. Sonic hedgehog regulates proliferation and differentiation of mesenchymal cells in the mouse metanephric kidney. Development 2002 129 : 5301 12.
18. Rubera I, Loffing J, Palmer LG et al. Collecting duct-specific gene inactivation of alphaENaC in the mouse kidney does not impair sodium and potassium balance. J. Clin. Invest. 2003 112 : 554 65.
19. Sequeira Lopez ML, Pentz ES, Nomasa T, Smithies O, Gomez RA. Renin cells are precursors for multiple cell types that switch to the renin phenotype when homeostasis is threatened. Dev. Cell 2004 6 : 719 28.
20. Shao X, Somlo S, Igarashi P. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J. Am. Soc. Nephrol. 2002 13 : 1837 46.
21. Ohyama T, Groves AK. Generation of Pax2-Cre mice by modification of a Pax2 bacterial artificial chromosome. Genesis 2004 38 : 195 9.
22. Bouchard M, Souabni A, Busslinger M. Tissue-specific expression of cre recombinase from the Pax8 locus. Genesis 2004 38 : 105 9.
23. Oxburgh L, Chu GC, Michael SK, Robertson EJ. TGFbeta superfamily signals are required for morphogenesis of the kidney mesenchyme progenitor population. Development 2004 131 : 4593 605.
24. Dymecki SM. Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice. Proc. Natl. Acad. Sci. USA 1996 93 : 6191 6.
25. Hirsch IB, Kelly J, Cooper S. Pulmonary edema associated with troglitazone therapy. Arch. Intern. Med. 1999 159 : 1811.
26. Fuchtenbusch M, Standl E, Schatz H. Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 2000 108 : 151 63.
27. Thomas ML, Lloyd SJ. Pulmonary edema associated with rosiglitazone and troglitazone. Ann. Pharmacother. 2001 35 : 123 4.
28. Walker AB, Naderali EK, Chattington PD, Buckingham RE, Williams G. Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. Diabetes 1998 47 : 810 14.
29. Yang T, Michele DE, Park J et al. Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney. Am. J. Physiol. 1999 277 : F966 73.
30. Chen L, Yang B, McNulty JA et al. GI262570, a PPARγ agonist, changes electrolytes and water reabsorption from the distal nephron in rats. J. Pharmacol. Exp. Ther. 2005 312 : 718 25.
31. Akiyama TE, Sakai S, Lambert G et al. Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol. CellBiol. 2002 22 : 2607 19.
32. Zhang H, Zhang A, Kohan DE, Nelson RD, Gonzalez FJ, Yang T. Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention. Proc. Natl. Acad. Sci. USA 2005 102 : 9406 11.
33. Guan Y, Hao C, Cha DR et al. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat. Med. 2005 11 : 861 6.
34. Bando Y, Ushiogi Y, Okafuji K, Toya D, Tanaka N, Fujisawa M. Troglitazone combination therapy in obese type 2 diabetic patients poorly controlled with alpha-glucosidase inhibitors. J. Int. Med. Res. 1999 27 : 53 64.
35. Yoshimoto T, Naruse M, Nishikawa M et al. Antihypertensive and vasculo- and renoprotective effects of pioglitazone in genetically obese diabetic rats. Am. J. Physiol. 1997 272 : E989 96.
36. Hosokawa M, Tsukada H, Fukuda K et al. Troglitazone inhibits bicarbonate secretion in rat and human duodenum. J. Pharmacol. Exp. Ther. 1999 290 : 1080 84.
37. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995 83 : 803 12.
38. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995 83 : 813 19.
39. Bell-Parikh LC, Ide T, Lawson JA, McNamara P, Reilly M, FitzGerald GA. Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J. Clin. Invest. 2003 112 : 945 55.
40. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 1999 5 : 698 701.
41. Schopfer FJ, Lin Y, Baker PR et al. Nitrolinoleic acid: An endogenous peroxisome proliferator-activated receptor gamma ligand. Proc. Natl. Acad. Sci. USA 2005 102 : 2340 45.
42. Eremina V, Sood M, Haigh J et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 2003 111 : 707 16.
43. Lin F, Hiesberger T, Cordes K et al. Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc. Natl. Acad. Sci. USA 2003 100 : 5286 91.
44. Gresh L, Fischer E, Reimann A et al. A transcriptional network in polycystic kidney disease. EMBO J. 2004 23 : 1657 68.
45. Qian CN, Knol J, Igarashi P et al. Cystic renal neoplasia following conditional inactivation of apc in mouse renal tubular epithelium. J. Biol. Chem. 2005 280 : 3938 45.
46. Ahn D, Ge Y, Stricklett PK et al. Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention. J. Clin. Invest. 2004 114 : 504 11.
47. Ge Y, Stricklett PK, Hughes AK, Yanagisawa M, Kohan DE. Collecting duct-specific knockout of the endothelin A receptor alters renal vasopressin responsiveness, but not sodium excretion or blood pressure. Am. J. Physiol. Renal Physiol. 2005 289 : F692 8.